Navigation Links


patient at medicine technology

Dade Behrings (hsCRP) Tests and BNTM Series Analyzers

... sample be collected for best results and that the patient have any inflammatory diseases resolved for at least two weeks prior to testing. The tests sensitivity is 0.2 mg/L. The test is standardized against the International Chemistry and Laboratory Medicine (IFCC)/Bureau Communautaire de Rfrence (BCR)/Co...

Monitoring Patient Glucose Levels: New Advances in software make it easier

Monitoring patient glucose levels and determining the response to int...ensive control is desired. As a result, improving patient monitoring and compliance has been a goal of many glucose-monitoring systems in recent years. Painle...

Digital vs. Analog Mammography

...manipulation. Information can also be coupled with patient information such as risk probability analysis or o...ilm mammogram, which must then be developed. Fewer patient callbacks because the ability to generate images within seconds and the flexibility to magnify and m...

Point of Care Strep Tests Speed Treatment, Lower Costs

...ion of group A streptococcal antigen directly from patient throat swab specimens. Two-color results provide c...ndicate, has contributed to timely, cost-effective patient care....

Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies

...or one to four weeks, together with the age of the patient (most typically adolescent) suggest the clinical diagnosis of (IM). Laboratory tests are usually advisable for confirmation. Serologic findings include a normal to moderately elevated white blood cell count, an increased total number of lymphocytes a...

Fast, Accurate Influenza A/B Antigen Detection

...t the presence of the influenza A and B virus in a patient nasal wash or nasal swab sample within 10 minutes. A positive test result is visually detected as a red colored test line. The test has an internal control that will appear as a visually detected blue colored line. The QuickVue Influenza test technol...

Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse

...te symptoms in many diseases and can insure that a patient is substance-free before undergoing medical procedures. Drug screening of pregnant women with a history of drug abuse may be useful as an educational tool and help guide treatment of the newborn. Some employers require a drug screen as part of an emp...

Prothrombin Time Comes in Small (CLIA-Waived) Packages

... on the reason for anticoagulation. For example, a patient having hip surgery, who is being anticoagulated to...two and three. To prevent arterial thrombosis in a patient with an artificial heart valve, the INR therapeutic goal may be in the 2.5- to 3.5-range. Several ...

Rapid Flu Tests May Prove Especially Helpful This Season

...t the presence of the influenza A and B virus in a patient nasal wash or nasal swab sample within 10 minutes. Quidels technology utilizes the principle of antibody specificity for the influenza virus nucleoprotein (NP) to selectively interact with the influenza A and B viruses. The NP is evolutionarily conse...

Analyzers Offer Point-of-Care Lipid Panels

...ma lipid test results an opportunity for effective patient counseling and therapeutic intervention. As with ... lipid values will continue to expand as a routine patient care activity. At the same time, the widespread competition in this field will likely yield even fas...

Genetic Analysis Systems Enter the Clinical Mainstream

...medical professionals powerful new ways to enhance patient management and care. As genetic screening technology grows more compact and simple to implement, test kits for laboratory and point of care diagnosis for a wide range of applications are entering the international marketplace. The uses of these kits ...

Hemoglobin Testing at the Point of Care

...f blood oxygenation can be an essential element of patient assessment, measurement of hemoglobin levels in the clinical setting is often desirable. In keeping with the recent trend to incorporate sophisticated technology into easily used point-of-care devices, recent products from several manufacturers offer...

Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance

...SA acquire it from an external source. Patient to patient spread is most frequently caused by health care providers after direct contact with patients. In January 2000, the Society for Healthcare Epidemiology of America (SHEA) Board of Directors made reducing antibiotic-resistant infections a strategic SH...

West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak

...ate June. The CDC has released few details on the patient but has confirmed this being 2005's first document...osts. The virus was first isolated from a febrile patient in the West Nile region of Uganda in 1937. It remained a little-understood cause of febrile illness...

Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.

...help clinicians apply pharmacogenetic knowledge to patient care. Probably the most important gene family to ...to account for the selectivity of BiDil). Since a patient can take several concurrent medications metabolized by the same CYP enzyme, it should come as no sur...

New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk

...disease, it has not been practical to screen every patient by directly assessing the arteries. Direct assays such as carotid ultrasound, coronary angiography, computed tomography angiography (CTA), and magnetic resonance angiography (MRA) are usually reserved for patients believed to have significant diseas...

Avian (Bird) Flu: Is There a Role for Rapid Tests?

...eas where avian flu is confirmed or suspected, any patient who meets the WHO case definition must have confirmatory testing. For surveillance of H5N1 in non-affected areas, rapid tests are never acceptable. Other drawbacks to rapid tests include potential compromises in biosafety, lesser performance early ...

Managing Preanalytical Processes for Patient Safety

..., MT (ASCP), MA Ed Contributing Editor Positive patient identification (ID) is a major put by healthcare a...he technology is here with wireless, simple-to-use patient ID systems. The decision boils down to features and cost. So how do you determine which product work...

Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal

...483-92). While a standard LDL-C panel may place a patient in the at-risk range for CAD, the breakdown of LDL subfractions may show that the patient is in fact, not at risk preventing overtreatment. In other cases, for patients that fall outside th...

Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control

...e glycemic control by changing either physician or patient behavior or both. They concluded that immediate feedback based on HbA1c results at the time of patient encounters resulted in a significant improvement of glycemic control at the 6-month follow-up and pe...

Hematology Analyzers Simple, Sophisticated Technology Serving All Patients

...ng systems. Analyzers can store weeks or months of patient data, retrieve it in a variety of report forms, or communicate with a host over a serial link. Quality control data management is offered in even the simplest cell counters, with programs ranging from basic QC data retrieval and analysis to internet-...

Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing

... analysis has revolutionized clinical medicine and patient care. During the 1960s, blood gas analysis became ...alysis system. Blood gas tests determine whether a patient has enough oxygen in his blood and whether or not that blood is pH balanced. The tests reveal levels...

Rapid HIV Testing Increases Possibility of Treatment

... result. By contrast, a rapid test will allow the patient immediate access to emotional counseling and medical treatments, as well as lifestyle education to address the further spread of HIV. The ability to rapidly screen for HIV at the point-of-care is likely to yield considerable emotional and medical be...

Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing

... near-patient testing can reduce costs and improve patient diagnosis, treatment and recovery time. Complete B...h as CBC and CRP measurement, concise decisions on patient management can be made. CRP testing is used in monitoring infection profiles by noting increasing le...

Optimizing Quality Control Data Management

...larly vital due to its impact on the validation of patient results. With the health and safety of patients a...e. In addition to the impact on the quality of patient care, decisions made based on quality control results have implications on laboratory credibility, o...

Urinalysis Analyzers: Large Capabilities in Every Size Device

... An optional barcode reader enables easy, reliable patient identification. PocketChem UA from Thermo Electro...arity values, minimizing errors. Memory stores 500 patient results for convenient data retrieval and 200 control results for regulatory documentation. An easil...

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

...due to cardiac events(myocardial infarction in one patient and arrhythmia, diminishedcardiac output, and hypotension in the other patient). The incidence of hypomagnesemia (both overall and severe [NCICTC Grades 3 & 4]) was increased in patients receiving ERBITUXalone or in combination with chemotherapy...

Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

... ASA404 arm and 38received chemotherapy alone. One patient in the ASA404 arm wasexcluded from the analysis of survival and one patient in thechemotherapy-alone arm was excluded from the independent analysesof response and time to tumou...

Antibiotics Don't Prevent Future Urinary Tract Infections, May Cause Resistance in Future Infections

...s long-standing commitment toproviding exceptional patient care, training new generations ofpediatric healthcare professionals and pioneering major researchinitiatives, Children's Hospital has fostered many discoveries thathave benefited children worldwide. Its pediatric research programis among the largest ...

Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting

...es that its technologies will allow introductionof patient friendly, cost-effective products which will provideequal or enhanced potency compared to those currentlyavailable. About Inspiration Biopharmaceuticals Founded in 2004, Inspiration Biopharmaceuticals is focused onrevolutionizing the treatment of h...

YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial

...ent. "These results, from this difficult to treat patient population,confirm that patients are able to perso... trial is expected to initiate enrollment ofits 50 patient target in the second half of 2007. The principalcoordinating investigator is Eugene Viscusi, MD, Dir...

New Information on the Potential of Plasmin Shared at ISTH Congress

... have uniqueproperties that could produce improved patient outcomes, and theseare currently being evaluated in the clinic." About Plasmin (Human), TAL-05-00018 Plasmin (Human), TAL-05-00018, is a plasma-derived thrombolyticprotein currently under development by Talecris Biotherapeutics fortreating acute pe...

Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy

...n's choice currently used for the treatment ofthis patient population. An interim look for the EXTEND trial isplanned for later this year. The Company is awaiting feedback from the FDA on the design of anew phase III trial of pixantrone for patients with indolent NHL.The trial, PIX303, will examine the comp...

Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone

...nical research toensure both accurate outcomes and patient safety. Based on positivepreclinical data on OE, c...oping potential therapeutics for large,underserved patient populations seeking superior treatments forconditions including psoriasis, atopic dermatitis (eczema...

AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

... that its partner Cook Medical hascompleted target patient enrollment and released six-monthfollow-up data fr...harma, gene andcell therapy and biotech to enhance patient safety and improveclinical outcomes. Cook won the prestigious Medical DeviceManufacturer of the Year...

Protox Announces Positive Clinical Data from Prostate Cancer Study

...his stage of theclinical development program in a patient population whichhas limited therapeutic options,"...tmentwere encountered in this clinical trial. One patient in thestudy, who met inclusion criteria in spite of havingborderline liver abnormalities, showed a ...

ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

...tifiesproprietary and related molecules for better patient treatment. Formore information, visit www.ziopharm.com. Forward-Looking Safe Harbor Statement: This press release contains forward-looking statements forZIOPHARM Oncology, Inc. that involve risks and uncertainties thatcould cause the Company's actu...

International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis

...ly and locally about theextent of the hospitalized patient population at risk for VTE andhow these patients a...eenidentified as the number #1 strategy to improve patient safety inthe hospital. If we want to improve hospital patient outcomes, weurgently need to implement...

NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

...day announcedthat Novartis Pharma AG has completed patient enrollment for PhaseIII clinical trials for NM100060, a topical treatment foronychomycosis (nail fungus). Pursuant to the terms of the licensingagreement with Novartis, NexMed will be entitled to a milestonepayment early next year. NexMed entered int...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

...minus 4days) has already been demonstrated in this patient population andis considered as the standard regime...5 weeksenoxaparin treatment versus 10 days in this patient population"said Professor Russell Hull from the University of Calgary, Canadaand Chair of the Steeri...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...ng cause of global mortality and a concernfor many patient populations, including those with atrialfibrillation at risk for stroke; those at risk for myocardialinfarction (heart attack); those undergoing orthopaedic surgery atrisk for developing DVT and PE; and hospitalized, medically illpatients immobilized...

Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

...l responses (as measured by the RECISTcriteria), 1 patient (8%) experienced an unconfirmed partialresponse an...s experienced ongoing stable disease(including one patient with a minor response). Individual patientstreated with CB7630 also experienced improvement in pain ...

Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings

...dosed with DAVANAT(R) incombination with 5-FU. One patient has tumor shrinkage of greaterthan 30%, a partial ...e expected to be active shortly. Abile duct cancer patient from the Phase I trial remained on studyfor 13 months, far exceeding expectations. "We are encourag...

MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial

...said. "The hepaticmasses almost disappeared." The patient survived for 12 months after treatment. "In the c...to educatingand supporting oncologists, optimizing patient care, disseminatingcancer-specific information to the public, and advocating patientrights. As an au...

Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer

...rExcision-Repair Cross-Complementing 1 (ERCC-1) in patient biopsieswith advanced non-small cell lung cancer (...ngpharmacogenomics to tailor treatment and improve patient outcomes,"said Kathleen Danenberg, President and CEO of Response Genetics."These results along with ...

Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis

...ymptom levels in both placebo andPreHistin-treated patient groups, thereby leaving no room todemonstrate a meaningful drug effect. In the randomized, six week, placebo-controlled trials involvinga total of 1,551 subjects, PreHistin did not achieve statisticallysignificant differences from placebo in the prim...

TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials

...,each given in addition to a BR. In both studies, patient randomization was stratified forenfuvirtide use in the BR (no use, re-use, or first time use),previous darunavir use (used or not), and screening plasma viralload ( =30,000 copies per mL). Patients with HIV-1 who were eligible for the DUET trials ha...

New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV

... quite some time.Adding only one active agent to a patient experiencing drug failureusually results in the rapid, predictable development of resistanceto that agent. Very seldom do patients get the chance to receivetwo potent new investigational agents in one clinical trial. TheDUET trials were one of the fi...

Stanford Researchers Find Brain Pathway of Depression in Rats

...l Center integrates research, medicaleducation and patient care at its three institutions -- StanfordUniversity School of Medicine, Stanford Hospital & Clinics andLucile Packard Children's Hospital at Stanford. For moreinformation, please visit the Web site of the medical center'sOffice of Communication ...

Avexa's Apricitabine Clinical Trial Update

...reatment in an extension study. Thelongest treated patient has successfully completed more than 18months of apricitabine therapy. One additional Serious AdverseEvent (hospitalization for a minor surgical procedure) has beenreported. However, like the three previously reported, thisincident was not associated...

From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials

...vidence to explain why a vaccine maylead to better patient survival, Schlom believes the evidencesuggests tha...esence of cancer antigens anddelivered back to the patient along with additional proteins thatfacilitate immune activation; and vector-based, where an engineer...

Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

...in clinical trials whereneither the doctor nor the patient knows if placebo or the activedrug substance is applied. EASI: Eczema Area and Severity Index (EASI), a commonly appliedtest to assess the extent and severity of AD. Hypersensitivity: an excessive immune reaction. Immunotherapeutic:a product aimed at...

Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients

...ariety of topics in cancerresearch, treatment, and patient care. AACR publishes five majorpeer-reviewed journals: Cancer Research; Clinical Cancer Research;Molecular Cancer Therapeutics; Molecular Cancer Research; andCancer Epidemiology, Biomarkers & Prevention. Its most recentpublication, CR, is a magaz...

Researchers Discover Method for Identifying How Cancer Evades the Immune System

...ariety of topics in cancerresearch, treatment, and patient care. AACR publishes five majorpeer-reviewed journals: Cancer Research; Clinical Cancer Research;Molecular Cancer Therapeutics; Molecular Cancer Research; andCancer Epidemiology, Biomarkers & Prevention. Its most recentpublication, CR, is a magaz...

Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics

...ariety oftopics in cancer research, treatment, and patient care. AACRpublishes five major peer-reviewed journ...ublication, CR, is a magazine forcancer survivors, patient advocates, their families, physicians,and scientists. It provides a forum for sharing essential,evid...

Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)

...withthe desired haemostatis (wound healing) in the patient whichresults in less bleeding complications. Pre-clinical in vivostudies confirmed Ablynx´s belief that ALX-0081 has uniquepotential to set a new standard in anti-thrombotic therapy based onits immediate onset of action, its high potency and si...

Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee

... importantin this typically elderly and vulnerable patient population and maypotentially offer a safer treatment option in the management ofchronic osteoarthritis pain. Importantly, the prolonged analgesiceffect resulting from a single or stepped dose, localizedadministration of Adlea does not seem to be ass...

Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial

...d to its overall bacteriologically evaluable patient database. -- Discontinuation rate -- from the modified intent-to-treat population, discontinuation rate due to adverse events was 1.6% for cethromycin and 2.8% for Biaxin(R). Total discontinuation rate (due to adverse events, cl...

Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine

...o days withoutincreased risk of side effects. If a patient requires a higher dose(300 mg), the therapeutic dose could be achieved after six days oftitration (100 mg for 2 days; 200 mg for 3 days then 300 mg on the6th day) without increased risk of side effects. "The results of the comparison of titration ...

Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

...ents in Stage 1 in order to proceed to Stage 2. No patient met the criteria for a PSA response and the median...ave already beenreported. The NCI has completed patient treatment in a Phase I clinicaltrial designed to evaluate the safety, tolerability andpharmacokineti...
Other Contentssynergidsyngamylymphocyteslymphocyteslymphocyteslymphocyteslymphocyteslymphocytessequencessequencessequencessequencessequencessequencessequencessequencestandemtandemtandemtandemtechnologytechnologytechnologytechnologytechnologytechnologytechnologytechnologytechnologytechnology
(Date:5/15/2008)...g-Hampton, Ph.D., Managing Director of Molecular B...collaborated with colleagues from around the world...s in chick and mouse model systems also play an im...tebral abnormalities. , The discovery was publi... of Human Genetics. , Working with samples from...
(Date:5/15/2008)... aggregate under floating objects, such as lengths... mammals. There is still no full explanation for t...ave seen purse-seine fishery operators take advant...ermen cast off floating rafts equipped with buoys ...ployed in a wide arc on either side of the vessel,...
(Date:5/15/2008)...lebrated brother will each receive honorary doctor... year each brother was named in the Queens Honours... Nottingham Research Professor in Chemistry, Marty...d playwright and director Stephen Poliakoff CBE, a...ble contribution to British science and culture. ...
(Date:5/14/2008)...n the greater risk for prostate cancer among Cauca...elp clinicians predict who is more likely to devel...the May 15, 2008, issue of Clinical Cancer Researc...r Research. , Currently, the most common method ...tate specific antigen test, but this method can id...
Breaking Biology News(10 mins):Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 3Boffinry and Baftas: Brothers' double doctorates 2Genes may play role in risk assessment for prostate cancer among Hispanics and caucasians 2VA Creating Advisory Panel on Rural Health 12372 1VA Creating Advisory Panel on Rural Health 12372 2Free Health Screenings Aim to Identify Risk of Heart Disease in Women 12369 1Free Health Screenings Aim to Identify Risk of Heart Disease in Women 12369 2TFAH Applauds Release of CDCs State Specific Public Health Emergency Preparedness Report 12366 1TFAH Applauds Release of CDCs State Specific Public Health Emergency Preparedness Report 12366 2Newly Published EPA RCRA Method 6800 Supports AIT Technology 3429 1Newly Published EPA RCRA Method 6800 Supports AIT Technology 3429 2
(Date:5/16/2008)...plc (LSE: HNT), "the Group",a leading internation...group headquartered in London, released its interi...rformance in the first quarter 2008 (the period,en...low., 15 May 2008, H...ement Statement, Record net new busine...
(Date:5/16/2008)... the lesson of helping others in t..., May 16 /PRNewswire/ -- In the aftermath of the,d...embers of China are,looking for ways to join in th...try, schools are running donation drives and fund-...Ms. Zhang Lijun, the 190-student strong,Nanjing Fu...
(Date:5/16/2008)...007, WASHINGTON, May 16 /PRNewswire-USNewswire/ -...ths, the National Cancer Institute (NCI) invested,...ncer research in 2007,according to updated statis... The two other federal agencies with significant c...trol and Prevention (CDC) and the,Department of De...
(Date:5/16/2008)...rce announced today the,hiring of John Mongeon as ...Mongeon formerly headed up the Government Services...ernment sales and marketing initiatives for,the CI...ions in the IT,industry., Mongeon, a resident of ... to spend more time with his two-year old son. In ...
Breaking Medicine News(10 mins):Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:Lung Cancer Still Lowest in Federal Funding 2
Other TagsGenieOther Tagsbeach 2troubling 2divide 2divide 3divide 4divide 5epidemics 2